tiprankstipranks
Crispr Therapeutics (CRSP)
NASDAQ:CRSP
US Market
CRSP
Crispr Therapeutics AG
RESEARCH TOOLSreports
Want to see CRSP full AI Analyst Report?

Crispr Therapeutics AG (CRSP) Stock News & Sentiment

10,941 Followers
Crispr Therapeutics Opens New Front in Cholesterol With CTX310 Trial
Premium
Company Announcements
Crispr Therapeutics Opens New Front in Cholesterol With CTX310 Trial
3d ago
CRSP
CRISPR Therapeutics Retains Buy Rating on Casgevy Momentum and 2026 Pipeline Catalysts Despite Price Target Trim to $83
Premium
Ratings
CRISPR Therapeutics Retains Buy Rating on Casgevy Momentum and 2026 Pipeline Catalysts Despite Price Target Trim to $83
20d ago
CRSP
CRISPR Therapeutics: Pipeline Expansion and In Vivo CAR-T Platform Support Buy Rating; $80 Price Target Reiterated
Premium
Ratings
CRISPR Therapeutics: Pipeline Expansion and In Vivo CAR-T Platform Support Buy Rating; $80 Price Target Reiterated
20d ago
CRSP
Reaffirming Buy on CRISPR Therapeutics: Conference Engagement and Gene-Editing Leadership Support Attractive Risk‑Reward
Premium
Ratings
Reaffirming Buy on CRISPR Therapeutics: Conference Engagement and Gene-Editing Leadership Support Attractive Risk‑Reward
1M ago
CRSP
Cathie Wood’s ARK Invest Dumps $2.1M Worth of META Shares; Stock Sinks
Premium
Market News
Cathie Wood’s ARK Invest Dumps $2.1M Worth of META Shares; Stock Sinks
2M ago
ARKF
ARKK
IHI, IHE, ARKG: Specialty Healthcare ETFs Offer Diversification and Growth to Investors
Premium
Market News
IHI, IHE, ARKG: Specialty Healthcare ETFs Offer Diversification and Growth to Investors
2M ago
BSX
IHE
Crispr Therapeutics Completes $600 Million Convertible Notes Offering
Premium
Company Announcements
Crispr Therapeutics Completes $600 Million Convertible Notes Offering
2M ago
8K
CRSP
More CRSP News >

CRSP News on the Web

Crispr Therapeutics Opens New Front in Cholesterol With CTX310 Trial
TipRanks News
Bullish
CRISPR Therapeutics Enters 'Second Phase' as CASGEVY Momentum Builds, Pipeline Data Looms
MarketBeat
Bullish
Analysts Are Bullish on These Healthcare Stocks: Crispr Therapeutics AG (CRSP), Caris Life Sciences, Inc. (CAI)
TipRanks News
Neutral
Crispr Therapeutics price target raised to $56 from $50 at Bernstein
TipRanks News
Bullish
FDA Commissioner Marty Makary resigns
TipRanks News
Neutral
1 Top Wall Street Analyst Thinks CRISPR Therapeutics Could More Than Double. Should You Buy the Stock Hand Over Fist? | The Motley Fool
Motley Fool
Bullish
Crispr Therapeutics price target raised to $76 from $74 at Evercore ISI
TipRanks News
Bullish
Crispr Therapeutics price target raised to $82 from $80 at Citi
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
CRSP
Sector Average
Media Buzz
This Week1 articles
Weekly Average6.25 articles
News Sentiment
This Week99%
Sector Average80%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CRSP’s Media Buzz Sentiment?
1 articles about CRSP were published this week. In an average week, 6.25 articles are published.
    What is CRSP’s weekly average amount of articles?
    In an average week, 6.25 articles about CRSP are published.
      What is CRSP’s News Sentiment?
      99% of articles about CRSP were positive this week, compared to its sector average of 80%.
        Healthcare Stocks that are Trending in the News
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        TLSATiziana Life Sciences
        JUNSJupiter Neurosciences, Inc.
        IMMXImmix Biopharma
        Showing the stocks with the most bullish news sentiment over the past week